These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19303366)

  • 21. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study.
    Valiathan R; Miguez MJ; Patel B; Arheart KL; Asthana D
    PLoS One; 2014; 9(5):e97698. PubMed ID: 24842313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.
    Eller MA; Blom KG; Gonzalez VD; Eller LA; Naluyima P; Laeyendecker O; Quinn TC; Kiwanuka N; Serwadda D; Sewankambo NK; Tasseneetrithep B; Wawer MJ; Gray RH; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
    PLoS One; 2011 Apr; 6(4):e18779. PubMed ID: 21526194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS.
    Karim R; Mack WJ; Kono N; Tien PC; Anastos K; Lazar J; Young M; Desai S; Golub ET; Kaplan RC; Hodis HN; Kovacs A
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):349-56. PubMed ID: 25314253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppression.
    Rousseau RK; Szadkowski L; Kovacs CM; Saikali MF; Nadeem R; Malazogu F; Huibner S; Cummins CL; Kaul R; Walmsley SL
    PLoS One; 2021; 16(7):e0254149. PubMed ID: 34320023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
    Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
    J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
    J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy.
    Charlebois ED; Ruel TD; Gasasira AF; Achan J; Kateera F; Akello C; Cao H; Dorsey G; Rosenthal PJ; Ssewanyana I; Kamya MR; Havlir DV
    J Acquir Immune Defic Syndr; 2010 Nov; 55(3):330-5. PubMed ID: 20592617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.
    Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK;
    AIDS; 2015 May; 29(8):911-9. PubMed ID: 25730509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.
    Lim A; French MA; Price P
    J Acquir Immune Defic Syndr; 2009 Jul; 51(3):248-57. PubMed ID: 19363449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
    Lange CG; Lederman MM; Madero JS; Medvik K; Asaad R; Pacheko C; Carranza C; Valdez H
    J Acquir Immune Defic Syndr; 2002 May; 30(1):33-40. PubMed ID: 12048361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
    Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
    Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
    Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
    Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy.
    Koblavi-Dème S; Maran M; Kabran N; Borget MY; Kalou M; Kestens L; Maurice C; Sassan-Morokro M; Ekpini ER; Roels TH; Chorba T; Nkengasong JN
    AIDS; 2003 Jul; 17 Suppl 3():S17-22. PubMed ID: 14565605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4/CD8 Ratio Predicts Peripheral Fat in HIV-Infected Population.
    Riangwiwat T; Kohorn LB; Chow DC; Souza SA; Ndhlovu LC; Wong JW; Gangcuangco LM; Shikuma CM
    J Acquir Immune Defic Syndr; 2016 May; 72(1):e17-9. PubMed ID: 26885805
    [No Abstract]   [Full Text] [Related]  

  • 37. T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi, Kenya.
    Buechler MB; Newman LP; Chohan BH; Njoroge A; Wamalwa D; Farquhar C
    Clin Exp Immunol; 2015 Sep; 181(3):451-6. PubMed ID: 25739813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians.
    Tsegaye A; Wolday D; Otto S; Petros B; Assefa T; Alebachew T; Hailu E; Adugna F; Measho W; Dorigo W; Fontanet AL; van Baarle D; Miedema F
    Clin Immunol; 2003 Dec; 109(3):338-46. PubMed ID: 14697749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
    Bisset LR; Cone RW; Huber W; Battegay M; Vernazza PL; Weber R; Grob PJ; Opravil M
    AIDS; 1998 Nov; 12(16):2115-23. PubMed ID: 9833852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.
    Ssewanyana I; Baker CA; Ruel T; Bousheri S; Kamya M; Dorsey G; Rosenthal PJ; Charlebois E; Havlir D; Cao H
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):65-71. PubMed ID: 19182922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.